Indication

Clear Cell Renal Carcinoma

2 clinical trials

3 products

Clinical trial

An Open-Label, Multi-Cohort, Two-Stage, Phase Ib/II Clinical Study to Evaluate the Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Treating Advanced Urological Tumors

Status: Not yet recruiting, Estimated PCD: 2025-08-31

Product

TT-00420 + Toripalimab

Clinical trial

A Phase I/II Study of Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)

Status: Recruiting, Estimated PCD: 2025-06-01

Product

Product